The Centers for Disease Control and Prevention (CDC) recently announced that the United States would admit Canadians administered with mixed COVID-19 vaccine doses. This guideline will be observed as soon as the U.S. border is reopened in November.
The CDC earlier pointed out that it does not recommend combining COVID-19 vaccines manufactured by different companies. However, the national public health agency withdrew from its previous announcement by saying that the practice of mixing one vaccine with another is becoming “increasingly common” in other countries.
Moreover, the CDC added that Canadians who were given any combination of the COVID-19 vaccines are considered “fully vaccinated.” However, the said vaccines should be approved by the World Health Organization (WHO) and the U.S. Food and Drug Administration (FDA) to be given clearance.
CDC’s announcement on Friday also confirmed that those who were given the AstraZeneca COVID-19 vaccine would be admitted to the U.S. border. While given approval by the WHO, the said vaccine was not given the green light by the U.S. FDA due to the possible adverse health effects that it can cause.
Notably, it isn’t just the AstraZeneca COVID-19 vaccine that has drawn flak since the roll-out of vaccines began.
Those manufactured by J&J, Pfizer, and Moderna were also complained of causing several severe health issues like the inflammation of the heart muscle, kidney failure, thrombosis, and even sudden death. Yet, despite these adverse side effects, governments and their allied health policymakers still push for the administration of the COVID-19 vaccine shots until now.
The CDC emphasized that only fully vaccinated individuals will be allowed to enter the U.S. border, which is slated to reopen on November 8. The border between Canada and the U.S. was officially closed in March of 2020 due to the pandemic.
In addition, while fully vaccinated Canadians who will travel to the U.S. will not be required to submit a negative COVID-19 test, they will be mandated to present one upon returning to Canada.
